| German G Kamalov, MD | |
|
5514 Corporate Dr Ste 150, Saint Joseph, MO 64507-7763 | |
| (816) 271-1265 | |
| (816) 271-4060 |
| Full Name | German G Kamalov |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 23 Years |
| Location | 5514 Corporate Dr Ste 150, Saint Joseph, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225259385 | NPI | - | NPPES |
| 200607530A | Medicaid | OK | |
| 186470001 | Medicaid | AR |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mosaic Life Care At St Joseph | Saint joseph, MO | Hospital |
| Ssm Health St. Francis Hospital- Maryville | Maryville, MO | Hospital |
| Mosaic Medical Center Albany | Albany, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mosaic Medical Center - Maryville | 3678813896 | 89 |
| Heartland Regional Medical Center | 6709772767 | 342 |
News Archive
Geneticists at Emory University School of Medicine have demonstrated a method that enables the routine amplification of all the genes on the X chromosome. The technology allows the rapid and highly accurate sequencing and identification of novel genetic variants affecting X chromosome genes.
Researchers at Weill Cornell Medical College have shown that it is possible to immunize mammals to control fertility. They say their technique could possibly be used on other mammals - including humans - because fertility hormones and their receptors are species-non-specific and are similar in both females and males. For pets, the technique could be an alternative to castration and adverse effects of hormone administration.
Pharmos Corporation (Pink Sheets: PARS) announced today the results of its Phase 2b Dextofisopam clinical trial to evaluate safety and efficacy of the compound in irritable bowel syndrome.
Math, biology and nanotechnology are becoming strange, yet effective bed-fellows in the fight against cancer treatment resistance. Researchers at the University of Waterloo and Harvard Medical School have engineered a revolutionary new approach to cancer treatment that pits a lethal combination of drugs together into a single nanoparticle.
An algorithm developed by faculty at The University of Texas Health Science Center at Houston can help physicians outside of major stroke treatment centers assess whether a patient suffering from ischemic stroke would benefit from an endovascular procedure to remove a clot blocking an artery.
› Verified 7 days ago
| Entity Name | Heartland Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477575405 PECOS PAC ID: 6709772767 Enrollment ID: O20040225001201 |
News Archive
Geneticists at Emory University School of Medicine have demonstrated a method that enables the routine amplification of all the genes on the X chromosome. The technology allows the rapid and highly accurate sequencing and identification of novel genetic variants affecting X chromosome genes.
Researchers at Weill Cornell Medical College have shown that it is possible to immunize mammals to control fertility. They say their technique could possibly be used on other mammals - including humans - because fertility hormones and their receptors are species-non-specific and are similar in both females and males. For pets, the technique could be an alternative to castration and adverse effects of hormone administration.
Pharmos Corporation (Pink Sheets: PARS) announced today the results of its Phase 2b Dextofisopam clinical trial to evaluate safety and efficacy of the compound in irritable bowel syndrome.
Math, biology and nanotechnology are becoming strange, yet effective bed-fellows in the fight against cancer treatment resistance. Researchers at the University of Waterloo and Harvard Medical School have engineered a revolutionary new approach to cancer treatment that pits a lethal combination of drugs together into a single nanoparticle.
An algorithm developed by faculty at The University of Texas Health Science Center at Houston can help physicians outside of major stroke treatment centers assess whether a patient suffering from ischemic stroke would benefit from an endovascular procedure to remove a clot blocking an artery.
› Verified 7 days ago
| Entity Name | Mosaic Medical Center - Maryville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184189797 PECOS PAC ID: 3678813896 Enrollment ID: O20190405001537 |
News Archive
Geneticists at Emory University School of Medicine have demonstrated a method that enables the routine amplification of all the genes on the X chromosome. The technology allows the rapid and highly accurate sequencing and identification of novel genetic variants affecting X chromosome genes.
Researchers at Weill Cornell Medical College have shown that it is possible to immunize mammals to control fertility. They say their technique could possibly be used on other mammals - including humans - because fertility hormones and their receptors are species-non-specific and are similar in both females and males. For pets, the technique could be an alternative to castration and adverse effects of hormone administration.
Pharmos Corporation (Pink Sheets: PARS) announced today the results of its Phase 2b Dextofisopam clinical trial to evaluate safety and efficacy of the compound in irritable bowel syndrome.
Math, biology and nanotechnology are becoming strange, yet effective bed-fellows in the fight against cancer treatment resistance. Researchers at the University of Waterloo and Harvard Medical School have engineered a revolutionary new approach to cancer treatment that pits a lethal combination of drugs together into a single nanoparticle.
An algorithm developed by faculty at The University of Texas Health Science Center at Houston can help physicians outside of major stroke treatment centers assess whether a patient suffering from ischemic stroke would benefit from an endovascular procedure to remove a clot blocking an artery.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| German G Kamalov, MD 1500 Dodson Ave, Suite 60, Fort Smith, AR 72901-5182 Ph: (479) 709-7325 | German G Kamalov, MD 5514 Corporate Dr Ste 150, Saint Joseph, MO 64507-7763 Ph: (816) 271-1265 |
News Archive
Geneticists at Emory University School of Medicine have demonstrated a method that enables the routine amplification of all the genes on the X chromosome. The technology allows the rapid and highly accurate sequencing and identification of novel genetic variants affecting X chromosome genes.
Researchers at Weill Cornell Medical College have shown that it is possible to immunize mammals to control fertility. They say their technique could possibly be used on other mammals - including humans - because fertility hormones and their receptors are species-non-specific and are similar in both females and males. For pets, the technique could be an alternative to castration and adverse effects of hormone administration.
Pharmos Corporation (Pink Sheets: PARS) announced today the results of its Phase 2b Dextofisopam clinical trial to evaluate safety and efficacy of the compound in irritable bowel syndrome.
Math, biology and nanotechnology are becoming strange, yet effective bed-fellows in the fight against cancer treatment resistance. Researchers at the University of Waterloo and Harvard Medical School have engineered a revolutionary new approach to cancer treatment that pits a lethal combination of drugs together into a single nanoparticle.
An algorithm developed by faculty at The University of Texas Health Science Center at Houston can help physicians outside of major stroke treatment centers assess whether a patient suffering from ischemic stroke would benefit from an endovascular procedure to remove a clot blocking an artery.
› Verified 7 days ago
Dr. Andre Joel Arsenault, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5325 Faraon St, Saint Joseph, MO 64506 Phone: 816-271-6406 Fax: 816-271-7986 | |
Robert C Clark, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 901 Heartland Rd, Ste 3800, Saint Joseph, MO 64506 Phone: 816-671-4800 Fax: 816-233-4021 | |
Issam El Bizri, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5325 Faraon St, Saint Joseph, MO 64506 Phone: 816-271-6406 Fax: 816-271-7986 | |
Bradley R Dyer, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5325 Faraon St, Ms 1020 Division Of General And Geriatric Medicine Univ, Saint Joseph, MO 64506 Phone: 816-271-6406 | |
Gita G Sprague, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5514 Corporate Dr Ste 120, Saint Joseph, MO 64507 Phone: 816-271-1350 Fax: 816-271-1355 | |
Federico Rivas-gotz, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5514 Corporate Dr Ste 120, Saint Joseph, MO 64507 Phone: 816-271-1350 Fax: 816-271-1355 | |
Dr. Vijay Kanakadandi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 802 N Riverside Rd Ste 220, Saint Joseph, MO 64507 Phone: 816-271-6155 |